Lipton Rogers, the developer behind 22 Bishopsgate, has joined forces with London-based start-up Galileo Labs in a bid to gain a £1.5bn foothold in the life sciences market.
The pair plans to amass a £1.5bn life sciences
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
